相关实验视频

Updated: Jan 13, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

概述多系统缩的当前管理和新兴疗法

Cristiano Sorrentino¹, Luca Baldelli^2,3, Giovanna Calandra-Buonaura^2,3

¹Neurological Clinic, AOU San Giovanni di Dio e Ruggi d'Aragona, Salerno, Italy.

Expert review of neurotherapeutics

|January 8, 2026

概括

多重系统缩 (MSA) 管理侧重于缓解症状和维持功能,因为没有疾病修饰治疗方法存在. 综合康复和非药物战略的多模式方法对于改善患者的治疗结果至关重要.

科学领域:

神经科学是一个神经科学.
神经学神经学
临床医学临床医学

背景情况:

多系统缩 (MSA) 是一种罕见的,零星的神经退行性疾病,其特点是帕金森症,小脑和金字塔体征以及自主性衰竭.
目前对MSA的管理策略主要是症状性的,因为缺乏疾病修饰疗法.

研究的目的:

批判性地评估当前关于多系统性缩 (MSA) 管理的证据.
突出新的治疗策略,并为临床实践和未来的研究提供指导.

主要方法:

使用PubMed进行了全面的文献搜索,没有日期限制.
确定并审查了与MSA运动和非运动症状管理相关的研究.

主要成果:

基于levodopa的干预措施为运动症状提供了部分和暂时的反应,特别是在MSA-P.
多巴胺激素激动剂,MAO-B抑制剂,阿曼塔丁和设备辅助疗法对运动症状提供了有限或短暂的益处.
多学科康复,包括物理治疗和职业治疗,是运动症状管理的组成部分.
非运动性症状的管理包括通过改变生活方式,药物药物和设备辅助干预来解决自主功能衰竭,胃肠道不运动和睡眠障碍.

结论:

治疗MSA在很大程度上仍然是症状性的,强调多模式治疗和整合康复和非药物战略.
正在进行的神经保护和神经调节的临床试验为改善MSA患者的长期结果提供了有希望的途径.

关键词:

多重系统缩多重系统缩自主功能障碍的自主功能障碍.改变疾病的试验.基于证据的治疗方法运动症状运动症状

更多相关视频

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

A Protocol for the Use of Remotely-Supervised Transcranial Direct Current Stimulation tDCS in Multiple Sclerosis MS

Published on: December 26, 2015

相关概念视频

Myasthenia Gravis: Overview and Treatment

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Methods of Documentation VI: Case Management Model

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...

Modeling in Therapy

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Drug Therapy

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications